At our Board of Directors Meeting held on September 28^th, 2018, we resolved to acquire shares of Institute of Cancer Immunology Co., Ltd and make the company a wholly owned subsidiary of DOJIN GROUP.

About the acquired company:

1. Company name：Institute of Cancer Immunology Co., Ltd
2. Headquarter：3-2-100, Shimonabe, Higashi-ku, Kumamoto, JAPAN
3. Representative：Tsuneo Kuramochif, Representative Director
4. Business：Manufacturing of immune cells and operation of cell producing center
5. Founded：January 4^th, 2013

* With the acquisition of the shares, Representative Director Tsuneo Kuramochi has filed a notice of resignation and been appointed as an medical advisor as of today.